Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 7:44 PM ET


Company Overview of Onconova Therapeutics, Inc.

Key Executives for Onconova Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Ramesh Kumar Ph.D.15 RelationshipsCo-Founder, Chief Executive Officer, President and Director59
E. Premkumar Reddy Ph.D.15 RelationshipsFounder, Lead Scientific Advisor and Director71
Ajay Bansal No RelationshipsChief Financial Officer and Secretary53
Thomas J. McKearn M.D., Ph.D.23 RelationshipsPresident of Research and Development66
Steven M. Fruchtman M.D.No RelationshipsChief Medical Officer and Senior Vice President of Research & Development64
View More Key Executives

Onconova Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael B. Hoffman J.D. 94 RelationshipsRiverstone Holdings LLC65
Ramesh Kumar Ph.D. 15 RelationshipsOnconova Therapeutics, Inc.59
E. Premkumar Reddy Ph.D. 15 RelationshipsOnconova Therapeutics, Inc.71
Alan R. Williamson Ph.D. 59 RelationshipsOnconova Therapeutics, Inc.78
Viren Mehta Pharma.D. 15 RelationshipsMehta Partners LLC65
View All Board Members

Onconova Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Anne M. VanLent61 Relationships4 Executives
Compensation Committee J.D.Michael B. Hoffman94 Relationships4 Executives
Nominating Committee Pharma.D.Viren Mehta15 Relationships3 Executives
Corporate Governance Committee Pharma.D.Viren Mehta15 Relationships3 Executives
Advisory Board Ph.D.Alan R. Williamson59 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$713.4K
Compensation as of Fiscal Year 2014
Onconova Therapeutics, Inc. CEO Compensation
Industry Average


Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET
Pental Ltd Announces Board Appointments
November 19, 2015 9:45 PM ET
Hipolin Ltd Announces Reconstitution of Audit, Nomination and Remuneration Committee
November 06, 2015 12:30 PM ET
Church & Dwight Co. Inc. Announces Management Changes
October 29, 2015 8:38 PM ET
SCA Appoints Anna Sävinger-Åslund as its new Senior Vice President, Group Function Human Resources, Effective from November 1, 2015
October 29, 2015 6:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Onconova Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at